January 27, 2004
Brand Name vs. Generic
Critics of the global AIDS initiative said that most of the money would go to Western pharmaceutical companies to purchase name-brand drugs instead of toward the purchase of locally produced generic antiretroviral drugs. However, U.S. Embassy Public Affairs Officer James Greene said, "The (U.S.) government is currently working out guidelines and a mechanism for buying the AIDS drugs. ... We will only know after two to three weeks where the drugs will be bought." Brennan said that Zambia will receive about $15 million in the next few weeks, with the balance expected to be made available by July. He added that Zambia's allocation of funding would increase in 2005 if the country could show that the initial funds were well-spent, according to Reuters (Shacinda, Reuters, 1/26).
Reprinted with permission from kaisernetwork.org. You can view the entire Kaiser Daily HIV/AIDS Report, search the archives, or sign up for email delivery at www.kaisernetwork.org/dailyreports/hiv. The Kaiser Daily HIV/AIDS Report is published for kaisernetwork.org, a free service of the Kaiser Family Foundation, by The Advisory Board Company. © 2004 by The Advisory Board Company and Kaiser Family Foundation. All rights reserved.